Hunan Fangsheng Pharmaceutical Co., Ltd.SSE: 603998

Announcement on Its Holding Subsidiary Obtaining the Drug Production License

· Issued by Hunan Fangsheng Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Hunan Fangsheng Pharmaceutical Co., Ltd. announced that its subsidiary, Guangdong Fangsheng Ronghua Pharmaceutical Co., Ltd., has obtained a drug production license from the Guangdong Provincial Drug Administration.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Its Holding Subsidiary Obtaining the Drug Production License

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Hunan Fangsheng Pharmaceutical Co., Ltd. on 6ix

Earlier from Hunan Fangsheng Pharmaceutical

Later from Hunan Fangsheng Pharmaceutical

All Hunan Fangsheng Pharmaceutical news releases